Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Amjad

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plastic and Reconstructive Surgery|December 24, 2002
Use of the radial forearm flap for deep, central, midfacial defectsD M Marshall, I Amjad, S Anthony Wolfe
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1995
Orbital fractures in childrenP J Koltai, I Amjad, D Meyer, et al.
Transplantation Proceedings|December 1, 1994
Fibroblasts diminish the insulin secretory response of HIT-T15 beta cells to glucoseM Aubrey, M Gallichio, I Amjad, et al.
International Journal of Clinical and Experimental Pathology|February 13, 2015
First reported case of a squamous cell carcinoma arising in the duodenum in a patient with Lynch syndromeAli I Amjad, Aatur D Singhi, Edward P Balaban, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 26, 2015
CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cellsKozue Sakao, Avani R Vyas, Sreenivasa R Chinni, et al.
Current Pharmacology Reports|November 12, 2015
Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to BedsideAli I Amjad, Rahul A Parikh, Leonard J Appleman, et al.
Immunobiology|June 8, 2026
Comprehensive bioinformatic and experimental approaches to analyze miR-200a, miR-1, and miR-548-3p expression and their targeted oxidative stress and glucose metabolic related hub genes in rheumatoid arthritisB Alzahrani, B Rauff, M R Chaudhry, et al.
Nature Medicine|March 20, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analysesRonan J Kelly, Blair V Landon, Ali H Zaidi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plastic and Reconstructive Surgery|December 24, 2002
Use of the radial forearm flap for deep, central, midfacial defectsD M Marshall, I Amjad, S Anthony Wolfe
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1995
Orbital fractures in childrenP J Koltai, I Amjad, D Meyer, et al.
Transplantation Proceedings|December 1, 1994
Fibroblasts diminish the insulin secretory response of HIT-T15 beta cells to glucoseM Aubrey, M Gallichio, I Amjad, et al.
International Journal of Clinical and Experimental Pathology|February 13, 2015
First reported case of a squamous cell carcinoma arising in the duodenum in a patient with Lynch syndromeAli I Amjad, Aatur D Singhi, Edward P Balaban, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 26, 2015
CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cellsKozue Sakao, Avani R Vyas, Sreenivasa R Chinni, et al.
Current Pharmacology Reports|November 12, 2015
Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to BedsideAli I Amjad, Rahul A Parikh, Leonard J Appleman, et al.
Immunobiology|June 8, 2026
Comprehensive bioinformatic and experimental approaches to analyze miR-200a, miR-1, and miR-548-3p expression and their targeted oxidative stress and glucose metabolic related hub genes in rheumatoid arthritisB Alzahrani, B Rauff, M R Chaudhry, et al.
Nature Medicine|March 20, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analysesRonan J Kelly, Blair V Landon, Ali H Zaidi, et al.
Pageof 1